Mark Malesker, PharmD, discusses the clinical evidence, drug interaction risks, and formulary challenges surrounding cannabinoid use for sleep disorders.

Objective: Health care resource utilization (HCRU) and cost among Medicaid patients with serious mental illness (SMI) were ...

AJMC: 64% of patients who responded to pCR skipped traditional chemotherapy entirely, and 97% avoided anthracyclines. For patients and oncologists, what does that mean in practice, and how do you ...

After decades of neglect, malnutrition-related diabetes, or type 5, is finally getting the research, recognition, and ...

In this episode titled, 'Understanding Neuroendocrine Carcinomas: Definitions, Types, and Clinical Presentation,' Ryan Haumschil ...